How to use the Lupus Low Disease Activity State (LLDAS) in clinical trials

Ioannis Parodis; Mandana Nikpour

Journal article

How to use the Lupus Low Disease Activity State (LLDAS) in clinical trials

Ioannis Parodis, Mandana Nikpour

ANNALS OF THE RHEUMATIC DISEASES | BMJ PUBLISHING GROUP | Published : 2021

DOI: 10.1136/annrheumdis-2019-215650

University of Melbourne Researchers

Mandana Nikpour Author Medicine - St Vincent's Hospital

Related Projects (1)

IMPROVING OUTCOMES IN SYSTEMIC AUTOIMMUNE DISEASE: A COLLABORATIVE AND INTERDISCIPLINARY PROGRAM OF RESEARCH

The multi-organ autoimmune diseases ‘scleroderma’ and ‘lupus’ have a profound negative impact on quality of life and life expectancy. The ov..

Grants

Awarded by Professor Nanna Svartz Foundation

Awarded by NHMRC Career Development Fellowship

Funding Acknowledgements

IP is supported by the Swedish Research Council, Professor Nanna Svartz Foundation (2017-00213 and 2018-00250), Swedish Rheumatism Association, King Gustaf V's 80-year Foundation, Stockholm County Council and Karolinska Institutet Foundations. MN is supported by an NHMRC Career Development Fellowship (APP1126370).